Connection

ANDREW LEE to Combined Modality Therapy

This is a "connection" page, showing publications ANDREW LEE has written about Combined Modality Therapy.
Connection Strength

0.426
  1. The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis. J Neuroophthalmol. 2021 Sep 01; 41(3):342-350.
    View in: PubMed
    Score: 0.145
  2. Neuro-Ophthalmic Manifestations of Pituitary Carcinoma. J Neuroophthalmol. 2018 09; 38(3):339-341.
    View in: PubMed
    Score: 0.117
  3. Acute myelogenous leukemia presenting with uveitis, optic disc edema, and granuloma annulare: Case report. Can J Ophthalmol. 2016 Oct; 51(5):e153-e155.
    View in: PubMed
    Score: 0.101
  4. Optic nerve meningiomas. Ophthalmology. 2003 Jul; 110(7):1282-3; author reply 1283.
    View in: PubMed
    Score: 0.041
  5. Subretinal neovascular membrane in idiopathic intracranial hypertension. Am J Ophthalmol. 2006 Mar; 141(3):573-4.
    View in: PubMed
    Score: 0.012
  6. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases. Binocul Vis Strabismus Q. 2002; 17(3):181-6.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.